Drug Trial Radar · NCT01379677
Rubidium-82 PET and Tc-99m-MIBI SPET: A Head to Head Comparison
Last checked: Nov 19, 2026Latest source record: May 14, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
135
Actual
Start
Feb 2011
Primary completion
Nov 2013
Study completion Nov 2013
Sponsor
- Lead sponsor
- Advanced Accelerator ApplicationsNovartis (NVS)
- Sponsor type
- Industry
- First posted
- Jun 23, 2011
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main purpose of this study is to compare myocardial perfusion imaging using Rubidium-82 PET with Tc-99m-MIBI SPET, in the evaluation of significant Coronary Artery Disease (CAD).
Conditions
- Coronary Artery Disease
Interventions
Rubidium-82Drug
Maximum dose allowed per injection: 2200 MBq Maximum cumulated dose allowed per examination: 4400 MBq Intravenous Use
Sestamibi. reconstitution with sodium pertechnetate (99mTc)Drug
Maximum dose allowed per injection: 1000 MBq Intravenous Use
Primary outcomes
What the sponsor says the trial is designed to measure.
- The specificity of detecting significant coronary artery disease (as defined as being >70% stenosis, on coronary CT angiography)Time frame: Up to 2 days
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University College Hospital London NHS Foundation Trust
London, London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.